Sequence information
Variant position: 1779 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1822 The length of the canonical sequence.
Location on the sequence:
EYSSITTTHTSATEPFLVDG
L TLGAQHLEAGGSLTRHVTQE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human EYSSITTTH-TSATEPFLVDGL TLGAQHLEAGGSLTRHVTQE
Mouse EFSSVTSTH-STTTEPFLMDGL TLGTQRLEAGGSLTRHVTQ
Rat EYSTVTSTHSTTTTEPFLIDGL TLGTQRLEAGGSLTRHVTQ
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
28 – 1822
Integrin beta-4
Topological domain
734 – 1822
Cytoplasmic
Modified residue
1791 – 1791
Phosphoserine
Alternative sequence
965 – 1822
Missing. In isoform Beta-4E.
Literature citations
Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells.
Suzuki S.; Naitoh Y.;
EMBO J. 9:757-763(1990)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-4A); VARIANT PRO-1779;
Cloning and sequence analysis of beta-4 cDNA: an integrin subunit that contains a unique 118 kd cytoplasmic domain.
Hogervorst F.; Kuikman I.; von Dem Borne A.E.G.K.; Sonnenberg A.;
EMBO J. 9:765-770(1990)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA-4B); VARIANT PRO-1779;
Genomic organization of the integrin beta 4 gene (ITGB4): a homozygous splice-site mutation in a patient with junctional epidermolysis bullosa associated with pyloric atresia.
Pulkkinen L.; Kurtz K.S.; Xu Y.; Bruckner-Tuderman L.; Uitto J.;
Lab. Invest. 76:823-833(1997)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS BETA-4A; BETA-4B AND BETA-4C); VARIANTS SER-1764 AND PRO-1779;
Genomic organization of the human integrin beta 4 gene.
Iacovacci S.; Gagnoux-Palacios L.; Zambruno G.; Meneguzzi G.; D'Alessio M.;
Mamm. Genome 8:448-450(1997)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS BETA-4A; BETA-4B AND BETA-4C); VARIANTS SER-1764 AND PRO-1779;
The unique cytoplasmic domain of the human integrin variant beta4E is produced by partial retention of intronic sequences.
van Leusden M.R.; Kuikman I.; Sonnenberg A.;
Biochem. Biophys. Res. Commun. 235:826-830(1997)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM BETA-4E); VARIANT PRO-1779;
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA-4A); VARIANT PRO-1779;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.